The main business of Changchun Gaoxin

Changchun Hi-Tech belongs to the pharmaceutical bio-industry, and its main business is biopharmaceuticals, production and sales of Chinese patent medicines, and real estate development.

：

Changchun High-tech Industry (Group) Co., Ltd.1993 In June, with the approval of Changchun Economic Restructuring Committee [1993] No.33, Changchun High-tech Industry Development Corporation adopted the method of directional offering to attract some social legal persons to participate in the establishment of joint-stock enterprises. Legal Representative Yang; Registered address: No.2400 Tongzhi Street, Changchun City. The company's shares were listed on the Shenzhen Stock Exchange on199665438+February 18, with the stock code of 00066 1, and the stock is referred to as Changchun Gaoxin for short.

scope of business

Development, production, sales and service infrastructure of high-tech products; Property management; Transfer of high-tech achievements and intermediary services; Commercial supply and marketing industry (except for goods with special restrictions by the state); Catering, entertainment, hotels (license required); Training, new drug development, technology transfer and consulting services; Central heating; Industrial investment (pharmaceutical industry) (the above items are limited to certified branches and subsidiaries). Greening landscape engineering design, construction and maintenance, enterprise marketing planning, advertising planning, social and economic information consulting, real estate intermediary services, housing sales agents (limited to branch certificate management); Enterprise management consulting (prohibited by the above national laws and regulations; Projects that need special approval shall not be operated without approval)

On March 27th, 2020, Changchun High-tech released its annual report, showing that the revenue in 20 19 was 7.374 billion yuan, up by 3.7.19% year-on-year, and the net profit was1775 million yuan, up by 76.36% year-on-year. Among them, the income of the pharmaceutical industry was 6.403 billion yuan, up 34.78% year-on-year, accounting for 86.63% of the income; Real estate revenue was 957 million yuan, up 58.04% year-on-year, accounting for 12.98% of revenue. In terms of operating profit, the pharmaceutical business also accounted for a large share, reaching 2.548 billion yuan, a year-on-year increase of 57.24%; The real estate industry realized an operating profit of 254 million yuan, a year-on-year increase of 124.75438+0%.

On June 3rd, 2020 1, 20 19, the top 500 listed companies ranked 143.

In 2020, it won the "ranking list of public welfare reputation of listed enterprises in COVID-19 medical and health industry in 2020" issued by iiMedia Ranking.

On August 8, 2020, with a brand value of 665,438+47 million yuan, Changchun Hi-Tech ranked 24th1in the list of the top 500 brands of China Brand Festival in 2020.